SMAD5 and hepatocellular carcinoma: For example, in hepatocellular carcinoma, MALAT1 upregulates SMAD5 expression by sequestering miR‐142‐3p, which promotes epithelial–mesenchymal transition and enhances tumor cell proliferation and invasiveness [21].